A. Rudenski

32.9k total citations · 1 hit paper
27 papers, 28.4k citations indexed

About

A. Rudenski is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, A. Rudenski has authored 27 papers receiving a total of 28.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in A. Rudenski's work include Metabolism, Diabetes, and Cancer (9 papers), Diabetes and associated disorders (7 papers) and Diabetes Treatment and Management (6 papers). A. Rudenski is often cited by papers focused on Metabolism, Diabetes, and Cancer (9 papers), Diabetes and associated disorders (7 papers) and Diabetes Treatment and Management (6 papers). A. Rudenski collaborates with scholars based in United Kingdom, India and United States. A. Rudenski's co-authors include R. C. Turner, David R. Matthews, J P Hosker, DF Treacher, B A Naylor, M. A. Burnett, Pauline Darling, Ronan O’Driscoll, John R. Gibson and Luke Howard and has published in prestigious journals such as The Lancet, Nature Medicine and Hepatology.

In The Last Decade

A. Rudenski

27 papers receiving 27.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1985 27.1k citations David R. Matthews, J P Hosker et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Rudenski United Kingdom	15	10.6k	8.5k	7.8k	5.2k	4.8k	27	28.4k
DF Treacher United Kingdom	11	10.0k 0.9×	8.3k 1.0×	7.9k 1.0×	5.0k 1.0×	4.7k 1.0×	19	27.8k
J P Hosker United Kingdom	11	10.4k 1.0×	8.4k 1.0×	7.7k 1.0×	5.1k 1.0×	4.7k 1.0×	15	27.8k
B A Naylor United Kingdom	8	10.2k 1.0×	8.3k 1.0×	7.7k 1.0×	5.0k 0.9×	4.7k 1.0×	12	27.4k
Dario Giugliano Italy	91	13.4k 1.3×	8.7k 1.0×	5.1k 0.6×	5.8k 1.1×	5.2k 1.1×	457	32.6k
Ulf Smith Sweden	92	6.8k 0.6×	11.7k 1.4×	8.4k 1.1×	8.6k 1.6×	3.8k 0.8×	394	27.5k
Clifton Bogardus United States	80	6.9k 0.6×	13.6k 1.6×	5.2k 0.7×	8.5k 1.6×	2.2k 0.5×	281	27.9k
Paresh Dandona United States	81	8.6k 0.8×	5.0k 0.6×	6.1k 0.8×	5.2k 1.0×	3.6k 0.8×	496	25.2k
Karen A. Donato United States	10	11.1k 1.0×	7.9k 0.9×	6.7k 0.9×	2.9k 0.6×	6.1k 1.3×	16	29.1k
Norbert Stefan Germany	81	7.4k 0.7×	7.7k 0.9×	9.8k 1.3×	5.9k 1.1×	3.9k 0.8×	338	23.6k
Michael J. Quon United States	80	6.7k 0.6×	8.1k 1.0×	5.8k 0.7×	9.0k 1.7×	5.1k 1.1×	203	26.6k

Countries citing papers authored by A. Rudenski

Since Specialization

Citations

This map shows the geographic impact of A. Rudenski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Rudenski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Rudenski more than expected).

Fields of papers citing papers by A. Rudenski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Rudenski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Rudenski. The network helps show where A. Rudenski may publish in the future.

Co-authorship network of co-authors of A. Rudenski

This figure shows the co-authorship network connecting the top 25 collaborators of A. Rudenski. A scholar is included among the top collaborators of A. Rudenski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Rudenski. A. Rudenski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rudenski, A., et al.. (2015). Relating oxygen partial pressure, saturation and content: the haemoglobin–oxygen dissociation curve. Breathe. 11(3). 194–201. 245 indexed citations

New, John P., Theingi Aung, Paul Baker, et al.. (2008). The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population‐based study. Diabetic Medicine. 25(5). 564–569. 60 indexed citations

Heald, Adrian, Simon Anderson, Jyoti C. Patel, et al.. (2007). Change in pancreatic B‐cell function (HOMA‐B) varies in different populations with similar genetic backgrounds but different environments. Diabetic Medicine. 24(2). 145–153. 6 indexed citations

Heald, Adrian, Jay Patel, Simon Anderson, et al.. (2007). Migration is associated with lower total, but not free testosterone levels in South Asian men. Clinical Endocrinology. 67(5). 651–655. 14 indexed citations

Buchan, Iain, Peter Baker, Jayne Houghton, et al.. (2007). The high prevalence of unrecognised anaemia among patients with diabetes and chronic kidney disease: a population-based e-Epidemiology study. Research Explorer (The University of Manchester). 1 indexed citations

Heald, AH, et al.. (2006). Insulin-like Growth Factor Binding Protein-2 (IGFBP-2) is a Marker for the Metabolic Syndrome. Experimental and Clinical Endocrinology & Diabetes. 114(7). 371–376. 106 indexed citations

Heald, AH, Ritika Sharma, Simon Anderson, et al.. (2005). Dietary intake and the insulin-like growth factor system: effects of migration in two related populations in India and Britain with markedly different dietary intake. Public Health Nutrition. 8(6). 620–627. 27 indexed citations

Heald, Adrian, Simon Anderson, Avni Vyas, et al.. (2005). Marked differences in the IGF system that are associated with migration in comparable populations of Gujaratis living in Sandwell, UK, and Gujarat, India. Diabetologia. 48(9). 1756–1765. 8 indexed citations

Heald, Adrian, Simon Anderson, Kennedy Cruickshank, et al.. (2005). Screening for insulin resistance in women with polycystic ovarian syndrome. Gynecological Endocrinology. 20(2). 84–91. 6 indexed citations

10.

Kealey, Terence & A. Rudenski. (1998). Endogenous Growth Theory for natural scientists. Nature Medicine. 4(9). 995–999. 3 indexed citations

11.

Rudenski, A. & David Halsall. (1998). Genetic testing for Gilbert’s syndrome: how useful is it in determining the cause of jaundice?. Clinical Chemistry. 44(8). 1604–1609. 14 indexed citations

12.

Rudenski, A., David R. Matthews, J Lévy, & R. C. Turner. (1991). Understanding “insulin resistance”: Both glucose resistance and insulin resistance are required to model human diabetes. Metabolism. 40(9). 908–917. 95 indexed citations

13.

Turner, R. C., A. Rudenski, David R. Matthews, et al.. (1990). Application of structural model of glucose-insulin relations to assess beta-cell function and insulin sensitivity.. PubMed. 24. 66–71. 20 indexed citations

14.

Snook, Jonathon, A. Rudenski, James Dooley, et al.. (1988). SERUM PROCOLLAGEN III N-TERMINAL PEPTIDE IN PRIMARY SCLEROSING CHOLANGITIS. Hepatology. 8. 1417–1417. 2 indexed citations

15.

Rudenski, A., David R. Hadden, A. B. Atkinson, et al.. (1988). Natural History of Pancreatic Islet B‐Cell Function in Type 2 Diabetes Mellitus Studied over Six Years by Homeostasis Model Assessment. Diabetic Medicine. 5(1). 36–41. 70 indexed citations

16.

O’Rahilly, Stephen, A. Rudenski, M. A. Burnett, et al.. (1986). BETA-CELL DYSFUNCTION, RATHER THAN INSULIN INSENSITIVITY, IS THE PRIMARY DEFECT IN FAMILIAL TYPE 2 DIABETES. The Lancet. 328(8503). 360–364. 184 indexed citations

17.

Turner, R. C., Rury R. Holman, David R. Matthews, et al.. (1986). Diabetes Nomenclature: Classification or Grading of Severity?. Diabetic Medicine. 3(3). 216–220. 8 indexed citations

18.

Hosker, J P, David R. Matthews, A. Rudenski, et al.. (1985). Continuous infusion of glucose with model assessment: measurement of insulin resistance and ?-cell function in man. Diabetologia. 28(7). 401–411. 235 indexed citations

19.

Matthews, David R., J P Hosker, A. Rudenski, et al.. (1985). Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7). 412–419. 27105 indexed citations breakdown →

20.

Hosker, J P, et al.. (1984). LOSS OF NORMAL SIGMOID, BETA-CELL DOSE-RESPONSE CURVE TO GLUCOSE IN NON-INSULIN-DEPENDENT DIABETES. Diabetologia. 27(2). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact